Annotation Detail for CCDC93

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C006780 |
bisphenol A |
bisphenol A results in decreased expression of CCDC93 mRNA | decreases expression | 20678512
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of CCDC93 mRNA | increases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of CCDC93 mRNA | increases expression | 20106945
|
D002117 |
Calcitriol |
Calcitriol results in increased expression of CCDC93 mRNA | increases expression | 16002434
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
4.29 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.35 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.35 | 11237771 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.62 | 17123778 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.71 | 11237771 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.79 | 12371664 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.21 | 19486331 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.44 | 15138306 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.28 | 19224547 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.70 | 12639820 12168785 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.85 | 8708960 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.05 | 15720958 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.21 | 10903974 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
3.53 | 16393666 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.16 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.54 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.08 | 12371664 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.51 | 16801185 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.16 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.65 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.48 | 11399458 16427766 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.62 | 11985600 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.59 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.58 | 10548101 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.41 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.63 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
3.35 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.35 | 16644109 16289102 15754350 18247401 12479363 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.33 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
5.42 | 10548101 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.84 | 8532709 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.61 | 16684133 16045194 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.73 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.71 | 1336536 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.16 | 17120751 |